Anti-inflammatory drugs in COVID-19

Abstract

Coronavirus disease 2019 (COVID-19) can lead to respiratory failure due to severe immune response. Treatment targeting this immune response might be beneficial. Early treatment of patients with COVID-19 pneumonia with tocilizumab and/or steroids was associated with better outcome.

Keywords

• corticosteroids
• covid-19
• tocilizumab